Mifepristone Mailing Restrictions May Take Effect Monday Under Court Order
A court order potentially effective Monday may prohibit doctors from mailing mifepristone, one of two drugs used in medication abortion. The restriction would increase barriers to access but abortion advocates indicate alternative pathways for mail-order abortion pills would remain available. The timing and full scope of enforcement remain unclear. For Medicaid managed care organizations, the development affects network provider compliance obligations and member access to covered reproductive health services where abortion is a covered benefit.
MCOs with abortion coverage must monitor provider compliance with evolving legal restrictions on medication abortion distribution methods and may need to revise utilization management protocols and member communications.
Managed Care · Maternal
You might also like